Vanadium inhibits DNA-protein cross-links and ameliorates surface level changes of aberrant crypt foci during 1,2-dimethylhydrazine induced rat colon carcinogenesis

Cell Biology and Toxicology

Volumn 21, Issue 1, 2005, Pages 41-52

  Suresh Kanna, P ^a   Saralaya, M G ^a   Samanta, K ^a   Chatterjee, M ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

1,2 dimethylhydrazine; Aberrant crypt foci; DNA protein cross links; Rat colon carcinogenesis; Scanning electron microscopy; Vanadium

Indexed keywords

1,2 DIMETHYLHYDRAZINE; AMMONIUM VANADATE; CARCINOGEN; CYTOCHROME P450; DNA; DRINKING WATER; GLUTATHIONE TRANSFERASE; PROTEINASE K; TUMOR MARKER; VANADIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURFACE; COLON CANCER; COLON CARCINOGENESIS; COMET ASSAY; CONTROLLED STUDY; CRYPT CELL; CYTOARCHITECTURE; DISEASE MARKER; DNA CROSS LINKING; DRUG EFFECT; DRUG METABOLISM; EVALUATION; FREQUENCY ANALYSIS; INTESTINE CELL; MALE; MALIGNANT TRANSFORMATION; MODULATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RAT; SCANNING ELECTRON MICROSCOPY; SUPPLEMENTATION;

1,2-DIMETHYLHYDRAZINE; ANIMALS; BODY WEIGHT; COLON; COLONIC NEOPLASMS; COMET ASSAY; CYTOCHROME P-450 ENZYME SYSTEM; DNA; DNA DAMAGE; GLUTATHIONE TRANSFERASE; INTESTINAL MUCOSA; MALE; MICROSCOPY, ELECTRON, SCANNING; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; VANADIUM;

ANIMALIA;

EID: 20044363659     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-005-1782-x     Document Type: Article

References (46)

1. Arutiunian AV, Prokopenko VM, Burmistrov SO et al. Free radical process in blood serum, liver and large bowel during 1,2 DMH induced carcinogenesis in rats. Vopr Onkol. 1997;43:618-22.
2. Barkla D, Tutton JM. Surface changes in the descending colon of rats treated with dimethylhydrazine. Cancer Res. 1977;37:262-71.
3. Beyhl FE. Action of ammonium meta vanadate on the activities of hepatic drug-metabolizing enzymes in vitro. Biochem Pharmacol. 1982;31:1458-61.
4. Benson AM, Hunkeler MJ, Talalay P. Increase of NAD (P) H: quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA. 1980;77:5216-20.
5. Bishayee A, Chatterjee M. Inhibition of altered liver cell foci and persistent nodule growth by vanadium during diethylnitrosamineinduced hepatocarcinogenesis in rat. Anticancer Res. 1995;15:455-62.
6. Bishayee A, Roy S, Chatterjee M. Characterization of selective induction and alteration of xenobiotic biotransforming enzymes by vanadium during diethylnitrosamineinduced chemical rat liver carcinogenesis. Oncol Res. 1999;11:41-53.
7. Byczkowski JZ, Kulkarni AP. Vanadium redox cycling, lipid peroxidation and co-oxygenation of benzo(a)pyrene-7,8-dihydrodiol. Biochim Biopys Acta. 1992;125:134-41.
8. Byrne AR, Kosta L. Vanadium in foods and human body fluids and tissues. Sci Total Environ. 1978;10:17-30.
9. Chakraborty T, Ghosh S, Datta S, Chakraborty P, Chatterjee M. Vanadium suppresses sister-chromatid exchange and DNA-protein crosslink formation and restores antioxidant status and hepatocellular architecture during 2-acetylaminofluorene-induced experimental rat hepatocarcinogenesis. J Exp Ther Oncol. 2003;3:346-62.
10. Chatterjee M, Bishayee A. Vanadium - a new tool for cancer prevention. In: Niragu JO, editor. Vanadium in the envrionment. Wiley. 1998:347-90.
11. Clapper ML, Kuzmich LM, Seestaller et al. Time course of glutathione S-transferase elevation in walker mammary carcinoma cells following chlorambucil exposures Biochem Pharmacol. 1993;45:683-90.
12. Cohen AM, Minsky BD, Schilsky RL. Cancer of the colon. In Devita VT Jr, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia, Lippincott-Raven. 1997:1144-97.
13. Combest WL, Johnson R. Detergentinduced distinction between fluoride and vanadate stimulated adenylate cyclases and their responses to guanine nucleotides. Arch Biochem Biophys. 1993;225:916-27.
14. Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: GHA Clowes Memorial Lecture. Cancer Res. 1982;42:4875-917.
15. Cook T, Kirkham N, Strainthorp DH, Inman C, Goeting N, Taylor I. Detection of early neoplastic changes in experimentally induced colorectal cancer using scanning electron microscopy and cell kinetic studies. Gut. 1984;25:748-55.
16. Crans DC, Bunch RJ, Theisen LA. Interaction of trace levels of vanadium (IV) and vanadium (V) in biological system. J Am Chem Soc. 1989;111:7597-607.
17. Djordjevic C. Antitumour activity of vanadium compounds. Met Ions Biol Syst. 1995;31:595-616.
18. Dreber D, Junod AF. Role of oxygen-free radicals in cancer development. Eur J Cancer. 1996;32:30-8.
19. Evangelou AM. Vanadium in cancer treatment. Crit Rev Oncol Hematol. 2002;42:249-65.
20. Gai PL, Kourtakis K. Solid-state defect mechanism in vanadyl pyrophosphate catalyst implications for selective oxidation. Science. 1995;267:661-3.
21. Guengerich FP. Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 1988;48:2946-54.
22. Jackson PE, O'Connor PJ, Cooper DP, Margison GP, Povey AC. Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis. 2003;24:527-33.
23. Kanna PS, Mahendrakumar CB, Tridib Chakraborty, P. Hemalatha, Pratik Banerjee, Chatterjee M. Effect of vanadium on aberrant crypt foci induced in 1,2-dimethylhydrazine. World J Gastroenterol. 2003;9:1020-7.
24. Krinsky NJ. Micronutrients and their influence on mutagenicity and malignant transformation. Ann NY Acad Sci. 1993;686:229-42.
25. Lowry OH, Rosenbrough NJ, Farr AI, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-75.
26. Manaevick B, Alin P, Gluthenbeg C. Identification of three classes of cytosolic glutathione transferase common to several mammalian species. Proc Natl Acad Sci USA. 1985;82:7202-6.
27. Maskens AP. Histogenesis of colon glands during postnatal growth. Acta Anat. 1978;100:17-26.
28. McLellan EA, Bird RP. Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res. 1988;48:6187-92.
29. Merk O, Reiser K, Speit G. Analysis of chromate-induced DNA-protein crosslinks with the comet assay. Mutat Res. 2000;471:71-80.
30. Oleinick LN, Chiu SM, Ramakrishnan N, Xue L. The formation, identification, and significance of DNA-protein cross-links in mammalian cells. Br J Cancer. 1987;55:135-40.
31. Omura T, Sato RJ. The carbon monoxide binding pigment of liver microsomes. J Biol Chem. 1964;239:2370-8.
32. Paulsen JE, Steffensen IL, Namork E, Alexander J. Scanning electron microscopy of aberrant crypt foci in rat colon. Carcinogenesis. 1994;15:2371-3.
33. Sardar S, Ghosh A, Mondal A, Chatterjee M. Protective role of vanadium in the survival of hosts during the growth of a transplantable murine lymphoma and its profound effect on the rats and patterns of biotransformation. Neoplasma. 1993;40:27-30.
34. Sato K. Glutathione S-transferases as markers of preneoplasia and neoplasia. Adv Cancer Res. 1990;52:205-55.
35. Shaham J, Bomstein Y, Meltzer A, Kaufman Z, Palma E, Ribak J. DNA-protein crosslinks, a biomarker of exposure to formaldehyde - in vitro and in vivo studies. Carcinogenesis. 1996;17:121-5.
36. Shi X, Dalal NS. Glutathione reductase functions as vanadate (V) reductase. Arch Biochem Biophys. 1990;278:228-90.
37. Snow ET. Metal carcinogenesis: mechanistic implications. Pharmacol Ther. 1992;53:31-65.
38. Sugiyama M, Wang XY, Costa M. Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse, and hamster cell lines. Cancer Res. 1986;46:4547-51.
39. Taioli E, Zhitkovich A, Kinney P, Udasin I, Toniolo P, Costa M. Increased DNA-protein crosslinks in lymphocytes of residents living in chromium-contaminated areas. Bio Trace Element Res. 1995;50:175-80.
40. Thompson HJ, Chasteen ND, Meeker LD. Dietary vanadyl (IV) sulfate inhibits chemically induced mammary carcinogenesis. Carcinogenesis. 1984;5:849-51.
41. Traynor OJ, Costa NL, Wood CB. A scanning electron microscopy study of changes in rat colonic mucosa during carcinogenesis. J Surg Res. 1986;41:529-37.
42. Wang JY, Prorok G, Vaughan WP. Cytotoxicity, DNA cross-linking, and DNA single-strand breaks induced by cyclophosphamide in a rat leukemia in vivo. Cancer Chem Pharmacol. 1993;3:381-6.
43. Ward TH, Butler J, Shahbakhti H, Richards JT. Comet assay studies on the activation of two diaziridinylbenzoquinones in K562 cells, Biochem Pharmacol. 1997;53:1115-21.
44. Weisburger JH. Causes, relevant mechanisms, and prevention of large bowel cancer. Semin Oncol. 1991;18:316-36.
45. Wu FY, Lee YJ, Chen DR, Kuo HW. Association of DNA-protein crosslinks and breast cancer. Mutat Res. 2002;501:69-78.
46. Zamble DB, Lippard SJ. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci. 1995;20:435-9.